Jayasuriya Anula
- SEC CIK
- 0001822933
No open-market purchases or sales filed in the past year.
Current role at each company
- LCTX Lineage Cell Therapeutics, Inc.Directoras of Jul 2, 2026
- JAGX Jaguar Health, Inc.Directoras of Dec 15, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jayasuriya Anula as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LCTX Lineage Cell Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 (view filing) | Dec 29, 2023 | 4 days | Jayasuriya AnulaDirector | PPurchaseCommon Shares, no par value | +10.0K | $1.09 | +$10.9K | New position10.0K after |